Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Avon Turnaround Progress Has Firm Training Sights On Growth

This article is powered by The Rose Sheet

Executive Summary

Direct seller says it is on track to realize up to $90m in cost savings in 2016, which it plans to reinvest in brand support and innovation, among other initiatives. Avon’s sales continue to suffer from negative currency effects, but in constant-dollar terms, its business advanced 4% in the second quarter, the firm reports.

You may also be interested in...



Avon Outlines Transformation, Cost-Savings Plan; Analysts Still Wary

Following Avon Products Inc.'s announcement last month that it will spin off its North American business, execs provide a strategy update for investors, including a $350m cost-savings plan.

In Brief: U.S. Cosmetic-Related Bills Gain Congressional Support; More

Support grows for federal bills to ban cosmetic animal testing and use of synthetic plastic microbeads in the U.S. More news in brief.

Unilever’s Dove Recommits To ‘Real Women’ Against Rising AI Threat

Unilever PLC’s Dove and Baby Dove brands continue tackling prominent social causes with a vow to be responsible about representing women realistically in advertising in the age of AI and a renewed commitment to closing the Black maternal care gap.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS108498

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel